ASFH: IOL Calculation After LASIK
Paper Discussed: Ianchulev T, Salz J, Hoffer K, et al.
Intraoperative optical refractive biometry for intraocular lens power estimation without axial length and keratometry measurements
Journal of Cataract Refractive Surgery, August 2005, 31(8) p1530-6
Guests: Sean Ianchulev, M.D.
Medical Director…
Transcend Medical Ready To Make Move In MIGs
Transcend Medical CMO Sean Ianchulev provides update on COMPASS trial and shares company’s plan for the FDA.
The Latest News and Notes, plus Conversation with Sean Ianchulev, MD, MPH
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, discuss the latest ophthalmic industry news and interview Sean Ianchulev, MD, MPH.
Welcome to the Eyeluminaries podcast :01
A review of the previous episode :23
News and notes with John and Jim 1:31
Alcon to acquire Aerie Pharmaceuticals 1:40…
Live from AAO Eyecelerator 2023
Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Vance Thompson, MD, Adrienne Graves, PhD, Sean Ianchulev, MD, and Kristen Harmon Igenito, live from AAO Eyecelerator.
Welcome to the Eyeluminaries podcast :01
Review of episode 19 1:31
Intro of Vance Thompson, MD 2:13
What is the…
Innovations in eye care with Steven Schwartz, MD, and Sean Ianchulev, MD (Re-Release)
In this special throwback episode, John Hovanesian, MD, and Jim Mazzo revisit their discussions with Steven Schwartz, MD, and Sean Ianculev, MD, about innovations, treatments and entrepreneurship in eye care.
Welcome to the Eyeluminaries podcast :10
About Steven Schwartz, MD 2:32
The interview…
Innovative Bio-Interventional Treatment for Glaucoma with Dr. Sean Ianchulev Iantrek TRANSCRIPT
Dr. Sean Ianchulev, CMO, previously CEO of Iantrek, is developing a new approach to treating glaucoma, which involves a biologic implant that can be customized to the patient's disease progression. This technology is designed to be more durable compared to traditional glaucoma treatments, which of…
Innovative Bio-Interventional Treatment for Glaucoma with Dr. Sean Ianchulev Iantrek
Dr. Sean Ianchulev, CMO, previously CEO of Iantrek, is developing a new approach to treating glaucoma, which involves a biologic implant that can be customized to the patient's disease progression. This technology is designed to be more durable compared to traditional glaucoma treatments, which of…
The Iantrek Journey: From Ideas to Impact in Ophthalmology
In this episode of Oracles of Eye Innovation, host Kris Morrill speaks with Dr. Sean Ianchulev (Chairman of the Board at Iantrek) and Adam Szaronos (CEO of Iantrek). Together, they share their journeys from clinical practice to driving startup success. From Sean’s journey from Bulgaria to Harvard, …
AI Beyond the Clinic
Cathleen McCabe, MD, speaks with Sean Ianchulev, MD, MPH, about his recent article in CRST’s January issue, “AI Beyond the Clinic,” which provides a deep dive on how regulation and reimbursement accelerate AI and home monitoring beyond exam lanes and into patients' homes. Dr. Ianchulev shares insig…
PODCAST SEARCH ENGINE
You can use our website to search 3,823,510 podcasts and 195,640,596 episodes by people, places, or topics.
An investment in knowledge pays the best interest, so I listen to podcasts.
‐ Benjamin "Llamacorn" Franklin
EDIT
Thank you for helping to keep the podcast database up to date.
